Blog Post
The CFIA is resuming the Plant Research Seminar Series
Looking to learn more about plant health? The CFIA is resuming the Plant Research Seminar and Fireside Chat Series after a brief pause in 2020 due to the COVID-19 pandemic. This series is an opportunity for CFIA plant scientists to share their research and engage with those who are interested in all things plant health.
Related posts
Blog Post
Getting ready to export: Key steps for businesses
Before you can take your products or services to the world and succeed in global markets, you need to prepare properly and ensure that you’re ready to export. The Trade Commissioner Service has prepared a quick guide to help you.
Blog Post, Regulatory
Consultation: Revised policy for Foods Derived from SCNT clones and their Progeny
Health Canada has launched a consultation on a revised policy regarding the regulation of foods derived from somatic cell nuclear transfer (SCNT) cloned cattle and swine, and their progeny. This consultation will be open for 60 days, from March 26 to May 25, 2024.
Blog Post, Regulatory
Food Processing: Severe Injuries in the Food Processing Industry Hazard Alert
This alert is directed to employers, contractors, staffing agencies and employees in the food processing industry, including cleaning and maintenance shifts, to increase awareness and help ensure the industry is taking action to reduce the alarming number of serious preventable injuries, including deaths, in poultry, meat and other food processing…
Blog Post
OMRI Updates Policies for Agricultural Ingredients and Processing Aids
In an effort to reduce confusion about certain products Listed in the Processing and Handling scope, OMRI has revised the OMRI Generic Materials List© (including the OMRI Standards Manual©) for review to the USDA NOP regulations. This revision is effective March 27, 2024.
Blog Post
Launch of Veterinary Drug Draft Guidance Consultations
Health Canada would like to inform you that they have recently launched consultations on the preparation of veterinary new drug submissions.
Comments are closed